Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LIBRITABS

CHLORDIAZEPOXIDE

Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview LIBRITABS is listed in Drugs@FDA under application 085481 (ANDA).

Marketing status: Discontinued Active ingredient CHLORDIAZEPOXIDE Form and strength TABLET;ORAL - 10MG Sponsor VALEANT PHARM INTL Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview LIBRITABS is listed in Drugs@FDA under application 085481 (ANDA). Marketing status: Discontinued Active ingredient CHLORDIAZEPOXIDE Form and strength TABLET;ORAL - 10MG Sponsor VALEANT PHARM INTL Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.